Factors Related to 6-Minute Walk Distance in Pulmonary Arterial Hypertension

Objective: The 6-minute walk test is the most commonly used tool for evaluating prognosis in patients withpulmonary arterial hypertension (PAH). This study aims to identify the parameters associated with 6-minutewalk distance (6MWD) and its changes over time.Methods: Sixty-three patients diagnosed with PAH or chronic thromboembolic pulmonary hypertensionbetween January 2005 and January 2013 were included in the study. Demographic, clinical, echocardiographic, hemodynamic data, and initial and follow-up 6MWD were recorded. The 6MWD cut-off wasdetermined based on previous studies. Patients were then categorized into groups based on their initial6MWD: ≥ 332 m or < 332 m.Results: Patients were followed up for 31.56 ± 15.07 months. In those with a 6MWD < 332m, diffusingcapacity of the lungs for carbon monoxide (DLCO) (P = .040), estimated glomerular filtration rate (P = .018),and partial arterial oxygen pressure (PaO2) (P = .024) were significantly lower, whereas age (P = .016), rightatrial pressure (P = .034), the frequency of pericardial effusion (P = .004), and mortality (P = .020) weresignificantly higher. Low DLCO was identified as an independent predictor of walking less than 332 meters(P = .048). In the subgroup analysis, among idiopathic PAH (IPAH) patients, DLCO (P = .024) was lower inthose with 6MWD < 332 m. In patients with scleroderma-associated PAH (SSc-PAH), systolic pulmonaryartery pressure (sPAP) (P = .018), and mean PAP (p = 0.034) were higher in patients with 6MWD < 332 m.When the change in 6MWD (Δ6MWD) was evaluated based on the difference between the initial 6MWDand at the end of the follow-up period, DLCO was lower in the group with a decreased 6MWD (P < .001).Conclusion: The study identified higher DLCO as an independent predictor of 6MWD ≥ 332 m and itsimprovement over time. In IPAH, 6MWD is more closely associated with DLCO and PaO2, whereas in SScPAH, PAPs play a more significant role.Cite this article as: Yurtseven E, Özcan S, Karadağ B, Öngen HG, Öngen Z. Factors related to 6-minute walk distance in pulmonaryarterial hypertension. Cerrahpaşa Med J 2025, 49, 0015, doi: 10.5152/cjm.2025.25015.

Authors

Institutions

Publication Details

Journal
Cerrahpasa Medical Journal
Published
2025-09-15
DOI
https://doi.org/10.5152/cjm.2025.25015
Primary Topic
Engineering Applied Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Factors Related to 6-Minute Walk Distance in Pulmonary Arterial Hypertension

Ece Yurtseven, Bilgehan Karadağ, Sevgi Özcan, Zeki Öngen et al.
Cerrahpasa Medical Journal
Engineering Applied Research
article

Factors Related to 6-Minute Walk Distance in Pulmonary Arterial Hypertension

Ece Yurtseven, Bilgehan Karadağ, Sevgi Özcan, Zeki Öngen, Hürrem Gül Öngen
article en

Abstract

Objective: The 6-minute walk test is the most commonly used tool for evaluating prognosis in patients withpulmonary arterial hypertension (PAH). This study aims to identify the parameters associated with 6-minutewalk distance (6MWD) and its changes over time.Methods: Sixty-three patients diagnosed with PAH or chronic thromboembolic pulmonary hypertensionbetween January 2005 and January 2013 were included in the study. Demographic, clinical, echocardiographic, hemodynamic data, and initial and follow-up 6MWD were recorded. The 6MWD cut-off wasdetermined based on previous studies. Patients were then categorized into groups based on their initial6MWD: ≥ 332 m or < 332 m.Results: Patients were followed up for 31.56 ± 15.07 months. In those with a 6MWD < 332m, diffusingcapacity of the lungs for carbon monoxide (DLCO) (P = .040), estimated glomerular filtration rate (P = .018),and partial arterial oxygen pressure (PaO2) (P = .024) were significantly lower, whereas age (P = .016), rightatrial pressure (P = .034), the frequency of pericardial effusion (P = .004), and mortality (P = .020) weresignificantly higher. Low DLCO was identified as an independent predictor of walking less than 332 meters(P = .048). In the subgroup analysis, among idiopathic PAH (IPAH) patients, DLCO (P = .024) was lower inthose with 6MWD < 332 m. In patients with scleroderma-associated PAH (SSc-PAH), systolic pulmonaryartery pressure (sPAP) (P = .018), and mean PAP (p = 0.034) were higher in patients with 6MWD < 332 m.When the change in 6MWD (Δ6MWD) was evaluated based on the difference between the initial 6MWDand at the end of the follow-up period, DLCO was lower in the group with a decreased 6MWD (P < .001).Conclusion: The study identified higher DLCO as an independent predictor of 6MWD ≥ 332 m and itsimprovement over time. In IPAH, 6MWD is more closely associated with DLCO and PaO2, whereas in SScPAH, PAPs play a more significant role.Cite this article as: Yurtseven E, Özcan S, Karadağ B, Öngen HG, Öngen Z. Factors related to 6-minute walk distance in pulmonaryarterial hypertension. Cerrahpaşa Med J 2025, 49, 0015, doi: 10.5152/cjm.2025.25015.

Cerrahpasa Medical JournalVol. 49(1)
Koç University (TR), Istanbul University-Cerrahpaşa (TR), Education Training And Research (US), Istanbul University (TR)
Openalex Percentile: Top 74%
Engineering Applied Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.